Odence-Ford Marion (CIK 1845002) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-13). Recent activity: Sell OPRX (1,386 shares), Buy OPRX (4,000 shares), Sell OPRX (4,051 shares), Buy OPRX (3,928 shares), Sell OPRX (1,153 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | OptimizeRx Corp (OPRX) | Chief Legal & Admin Officer | Sell | 1,386 | $12,793 |
| 2026-02-13 | OptimizeRx Corp (OPRX) | Chief Legal & Admin Officer | Buy | 4,000 | $0 |
| 2025-12-23 | OptimizeRx Corp (OPRX) | Chief Legal & Admin Officer | Sell | 4,051 | $51,610 |
| 2025-12-22 | OptimizeRx Corp (OPRX) | Chief Legal & Admin Officer | Buy | 3,928 | $0 |
| 2025-12-22 | OptimizeRx Corp (OPRX) | Chief Legal & Admin Officer | Sell | 1,153 | $15,577 |
| 2025-10-07 | OptimizeRx Corp (OPRX) | Chief Legal & Admin Officer | Buy | 6,649 | $0 |
| 2025-10-07 | OptimizeRx Corp (OPRX) | Chief Legal & Admin Officer | Sell | 1,952 | $36,600 |
| 2025-08-25 | OptimizeRx Corp (OPRX) | Chief Legal & Admin Officer | Buy | 15,625 | $0 |
| 2025-03-04 | OptimizeRx Corp (OPRX) | Chief Legal Officer & CHRO | Buy | 771 | $0 |
| 2025-03-04 | OptimizeRx Corp (OPRX) | Chief Legal Officer & CHRO | Sell | 268 | $1,388 |
| 2025-02-20 | OptimizeRx Corp (OPRX) | Chief Legal Officer & CHRO | Sell | 1,479 | $9,821 |
| 2025-02-13 | OptimizeRx Corp (OPRX) | General Counsel and CCO | Buy | 4,000 | $0 |
| 2025-02-13 | OptimizeRx Corp (OPRX) | General Counsel and CCO | Sell | 1,386 | $7,762 |
Source: SEC Form 4 filings · as of 2026-02-13